hero image
Nicholas J. Petrelli, M.D. - ChristianaCare. Newark, DE, US

Nicholas J. Petrelli, M.D. Nicholas J. Petrelli, M.D.

Bank of America endowed medical director, Helen F. Graham Cancer Center and Research Institute | ChristianaCare

Newark, DE, UNITED STATES

Nicholas J. Petrelli is a nationally recognized expert on cancer.

Biography

Dr. Nicholas J. Petrelli is a nationally recognized expert on colorectal cancer, joined ChristianaCare as the Bank of America endowed medical director of the Helen F. Graham Cancer Center and Research Institute in August 2001. As medical director, Dr. Petrelli oversees the state’s largest and most technologically advanced cancer program, including cancer detection, diagnosis and treatment. Under his leadership the Graham Cancer Center was selected as a National Cancer Institute Community Oncology Research Program (NCORP) and one of the original 16 NCI Community Cancer Centers Programs (NCCCP).

Dr. Petrelli came to ChristianaCare from one of the nation’s leading NCI Designated Cancer Centers, Roswell Park Cancer Institute in Buffalo, NY, where he led several clinical trials for a promising form of chemotherapy. He has conducted substantial research into the genetics of colorectal cancer and co-authored more than 300 manuscripts in peer-reviewed journals as well as 36 book chapters.

Areas of Expertise (5)

Colorectal Cancer

Cancer Care Management

Cancer Detection

Cancer clinical trials

Surgical Oncology

Education (3)

Tulane University Medical School: MD 1973

University of Notre Dame: BA 1969

Roswell Park Cancer Institute: Surgical Oncology Fellowship

1978-1980

Multimedia

Publications:

Documents:

Photos:

Videos:

With your support, we're reducing cancer rates in Delaware Cancer Doesn’t Stop for a Pandemic and Neither Do We Christiana Care Virtual Reality at the Helen F. Graham Cancer Center & Research Institute Heart and Cancer Care During the COVID-19 Pandemic

Audio:

Media Appearances (3)

Petrelli receives Tilton Award from Medical Society of Delaware

Dover Post  

2019-10-10

Nicholas J. Petrelli, Bank of America endowed medical director of ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, received the Tilton Award from the Medical Society of Delaware on Oct. 4.

view more

Delaware-developed CRISPR cancer therapy edging closer to human testing

Philadelphia Business Journal  

2019-05-06

Dr. Nicholas J. Petrelli, medical director of the Helen F. Graham Cancer Center & Research Institute at ChristianaCare, said the study — if approved — would put the Wilmington health system in a position to capture a trio of firsts. “It will be the first lung cancer clinical trial carried out by a gene editing program embedded in a community cancer center,” Petrelli said. “While our Gene Editing Institute has a great deal of translational research experience, this will be its first study to move scientific discovery toward an IND. And, it will also be the first time that we will be investigating technology that was grown organically at the Gene Editing Institute.”...

view more

ChristianaCare’s Gene Editing Institute takes the next step toward its first investigational drug application for FDA approval to treat lung cancer using CRISPR

BioSpace  

2019-04-30

“This exciting study represents a trio of firsts,” said Nicholas J. Petrelli, M.D., FACS, Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute at ChristianaCare. “It will be the first lung cancer clinical trial carried out by a gene editing program embedded in a community cancer center. While our Gene Editing Institute has a great deal of translational research experience, this will be its first study to move scientific discovery toward an IND application. And, it will also be the first time that we will be investigating technology that was grown organically at the Gene Editing Institute.”

view more

Selected Papers and Publications (6)

High volume pancreaticoduodenectomy performed at an academic community cancer center

American Journal of Surgery, 218(2): 349 -354

Sabesan A, Gough B, Anderson C, Abdel-Misih RZ, Petrelli NJ, Bennett JJ.

2019

Folates as adjuvants to anticancer agents: chemical rationale and mechanism of action

Critical Reviews in Hematology/Oncology, 106: 118-131

Danenberg P, Gustavsson B, Johnston P, Lundberg P, Moser R, Odin E. Peters G, Petrelli N.

2016.

Operative approach to rectal cancer: an anatomical and technical description

Surgical Oncology: 27(2)

Khatri VP, Rodrigues-Bigas MA, Flewell R, Petrelli NJ.

2018

The impact of multidisciplinary care on processes of cancer care: a multi institutional study

Journal of Oncology Practice, 12(2): 155-156

Onukwugha E, Petrelli N, Castro K, Gardner J, Jayasekera J, Gohoubava O, Tan M, McNamara E, Zaren HA, Asfeldt T, Bearden J, Salner A, Krasna MJ, Praghu D, Clauser SB.

2016

A review of the evolution of systemic therapy in the management of colorectal cancer

Clinical Colorectal Cancer, 14(1), 1-10

Gustavsson CG, Machover D, Petrelli N, Roth A, Schmoll H, Tveit K, Gibson F.

2015

Responsibility for costs associated with clinical trials

J Clin Oncol, 32(30): 3357-59

Martin P, Ennis N, Petrelli N, Stewart F, Appelbaum F, Benson A.

2014

External Service & Affiliations (3)

  • Annals of Surgical Oncology : Associate Editor
  • Surgical Oncology Clinics of North America : Editor
  • Surgical Oncology : Co-Editor

Selected Honors & Awards (3)

Clinical Research Award

2014 Association of Community Cancer Centers

American Cancer Society Clinical Oncology Fellowship Award

1980

American Cancer Society Clinical Oncology Fellowship Award

1979